Skip to main content

Flucelvax Quadrivalent FDA Approval History

Last updated by Judith Stewart, BPharm on Sep 8, 2021.

FDA Approved: Yes (First approved May 23, 2016)
Brand name: Flucelvax Quadrivalent
Generic name: influenza virus vaccine, inactivated
Company: Seqirus
Treatment for: Influenza Prophylaxis

Flucelvax Quadrivalent is an inactivated influenza vaccine indicated for active immunization for active immunization against influenza disease in people 2 years of age and older.

Development timeline for Flucelvax Quadrivalent

DateArticle
May 23, 2016Approval Seqirus Receives FDA Approval for Flucelvax Quadrivalent (Influenza Vaccine) for People Four Years of Age and Older
Nov 21, 2012Approval FDA Approves Flucelvax - First Seasonal Influenza Vaccine Manufactured Using Cell Culture Technology

See also

Flucelvax Quadrivalent (influenza virus vaccine, inactivated) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer